Comparative Pharmacology
Head-to-head clinical analysis: GRISEOFULVIN ULTRAMICROSIZE versus HALOTEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GRISEOFULVIN ULTRAMICROSIZE versus HALOTEX.
GRISEOFULVIN, ULTRAMICROSIZE vs HALOTEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Binds to tubulin, disrupting microtubule function and inhibiting fungal cell mitosis; deposited in keratin precursor cells, making keratin resistant to fungal invasion.
Halotex (haloprogin) is a topical antifungal agent that disrupts fungal cell membrane permeability and inhibits ergosterol synthesis, leading to cell death.
250-375 mg orally once daily or 500-750 mg orally once daily for severe infections.
Apply topically twice daily for 2-4 weeks; tinea pedis may require up to 6 weeks.
None Documented
None Documented
9-24 hours (mean 15 hours); prolonged in liver disease.
Not well characterized; estimated terminal half-life approximately 24-48 hours based on limited data.
Renal (<1% unchanged); fecal (36% as metabolites); tissue deposition may persist for weeks.
Primarily fecal (biliary) as unchanged drug and metabolites; negligible renal excretion (<1%).
Category D/X
Category C
Antifungal
Antifungal